Print Page     Close Window     

SEC Filings

20-F
IKANG HEALTHCARE GROUP, INC. filed this Form 20-F on 08/10/2018
Entire Document
 

Table of Contents

 

IKANG HEALTHCARE GROUP, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of US dollars, except share and per share data, or otherwise noted)

 

 

 

For the years ended March 31,

 

 

 

2016

 

2017

 

2018

 

Net revenues

 

$

370,812

 

$

435,713

 

$

563,932

 

Cost of revenues

 

210,909

 

262,134

 

325,656

 

 

 

 

 

 

 

 

 

Gross profit

 

159,903

 

173,579

 

238,276

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Selling and marketing expenses

 

64,763

 

74,304

 

96,594

 

General and administrative expenses (including share-based compensation expenses of $1,949, $1,941 and $34,822 in 2016, 2017 and 2018, respectively)

 

65,422

 

82,783

 

126,255

 

Research and development expenses

 

3,716

 

3,194

 

3,055

 

 

 

 

 

 

 

 

 

Total operating expenses

 

133,901

 

160,281

 

225,904

 

 

 

 

 

 

 

 

 

Income from operations

 

26,002

 

13,298

 

12,372

 

Interest expense

 

(4,603

)

(13,880

)

(20,191

)

Interest income

 

785

 

939

 

382

 

Other income

 

1,874

 

 

 

 

 

 

 

 

 

 

 

Income/(loss) before provision for income taxes and gain/(loss) from equity method investments

 

24,058

 

357

 

(7,437

)

Income tax expenses

 

5,838

 

3,354

 

6,791

 

 

 

 

 

 

 

 

 

Income/(loss) before loss from equity method investments

 

18,220

 

(2,997

)

(14,228

)

Loss from equity method investments

 

(1,732

)

(9,547

)

(2,448

)

 

 

 

 

 

 

 

 

Net income/(loss)

 

16,488

 

(12,544

)

(16,676

)

Less: Net income/(loss) attributable to non-controlling interest

 

(1,837

)

(1,293

)

633

 

 

 

 

 

 

 

 

 

Net income/(loss) attributable to iKang Healthcare Group, Inc.

 

18,325

 

(11,251

)

(17,309

)

 

 

 

 

 

 

 

 

Net income/(loss) attributable to common shareholders of iKang Healthcare Group, Inc.

 

$

18,325

 

$

(11,251

)

$

(17,309

)

 

 

 

 

 

 

 

 

Net income/(loss) per share attributable to common shareholders of iKang Healthcare Group, Inc.

 

 

 

 

 

 

 

Basic

 

$

0.55

 

$

(0.33

)

$

(0.50

)

Diluted

 

$

0.54

 

$

(0.33

)

$

(0.50

)

 

 

 

 

 

 

 

 

Weighted average shares used in calculating net income (loss) per common share

 

 

 

 

 

 

 

Basic

 

33,583,005

 

34,060,579

 

34,295,160

 

Diluted

 

34,235,542

 

34,060,579

 

34,295,160

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5



Copyright © 2015- iKang Healthcare Group, Inc. All Rights Reserved.